Zhuhai federated pharmaceutical co., LTD., located in zhuhai jinwan district sanzao science and technology industrial park, was built and put into operation in 1998, covering an area of 330,000 square meters. Is a collection of production, research and development, sales in one of the high-tech modern comprehensive pharmaceutical enterprises.

The main products of zhuhai company are: 5 kinds of antibiotic preparation, 5 series of antibiotic raw material products and 46 kinds. There are 2 series and 6 varieties of biological products insulin. Among them, oral semisynthetic penicillin API has the largest production workshop of similar products in China at present, with an annual capacity of more than 5000 tons, and the products have a high share in domestic and export markets. "Gold" and "Silver" brand carat series products with an annual output of about 1000 tons, the products are exported to overseas.

Zhuhai Company built a large insulin production base. In 2010, the second generation of insulin recombinant human insulin (USLIN® series) was successfully marketed. At the beginning of 2017, the third generation insulin analogue insulin glargine (ULEN ® series) was launched on the market. Zhuhai Company is the only company that produces insulin products by genetically engineered yeast expression technology in China, and has the first insulin pre-filling pen assembly line in China, with an annual output of 3 tons of insulin raw materials and about 300 million preparations, with an annual output value of more than 10 billion yuan. At the same time, zhuhai company is also the production base of federal pharmaceutical peptide cosmetics raw material brand "federal peptide beauty".